Viyash Scientific Limited (VIYASH) — Announcement

· NSE 🔴 High Importance Neutral
📢 Key Event
ICRA upgrades Viyash Scientific's working capital facility rating to [ICRA]AA- (Stable)
🔄 What Changed
Upgraded from IND A/Positive/IND A1 to [ICRA]AA- (Stable)
💡 Investor Takeaway
The upgraded stable rating signals stronger short-term creditworthiness for Viyash Scientific's working capital facilities.
⚠️ Risks
Rating will undergo surveillance within one year; any term changes require ICRA review

Viyash Scientific announced ICRA assigned a stable [ICRA]AA- rating to its 185.00 Crores fund-based working capital facilities, upgrading from India Ratings' prior IND A/Positive/IND A1. The rating letter was issued April 22, 2026, and is available on the company website.

📄 View Original Announcement (PDF)

About Viyash Scientific Limited (VIYASH)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹9,809.42 Cr P/E: 488.1

View full VIYASH stock details →

📡 Get AI alerts when VIYASH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIYASH — Free

📊 More VIYASH filings

See all VIYASH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIYASH files new disclosures

Track VIYASH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIYASH — Free

Free account · 2 AI queries/day